Medicare and Medicaid
Our work in Medicare and Medicaid
-
Reverse Reference Pricing: Rewarding Patients For Reducing Medicare Costs
Neeraj Sood and Christopher Whaley write that it is time for Medicare to apply the lessons learned by private insurers to incentivize price shopping by patients.
Categorized in -
Paul Ginsburg Appointed Vice-Chair of the Medicare Payment Advisory Commission
Paul Ginsburg has served on the committee, which is tasked with formulating recommendations to Congress on issues related to access, quality, and cost in Medicare, since 2016.
-
Breaking Down The Bipartisan Senate Group’s New Proposal To Address Surprise Billing
Like other recent federal bills (and state laws), the bipartisan Senate legislation protects patients from surprise out-of-network bills through a “billing regulation” approach.
Categorized in -
Analyzing the House E&C Committee’s Bipartisan Surprise Out-Of-Network Billing Proposal
The Energy and Commerce draft would eliminate surprise out-of-network billing for both emergency and non-emergency services (with the notable exception of ambulance services) and across different sites of care (e.g., hospitals, ambulatory surgery centers (ASCs), freestanding emergency departments).
Categorized in -
Medicare Physician Payment Reform After Two Years: Examining MACRA Implementation and the Road Ahead
Matthew Fiedler spoke at the Senate Finance Committee on May 8 about the implementation of the Medicare physician payment provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Categorized in -
Impact of Oncology Drug Shortages on Chemotherapy Treatment
Jacobson and Alpert studied more than 2.4 million monthly claims for chemotherapy treatment and found little impact on outpatient chemotherapy treatment for the majority of oncology drugs identified as experiencing shortages between 2004 and 2011.
Categorized in -
Cancer Drug Shortages Result in Almost no Treatment Changes, USC Study Finds
Jacobson and Alpert studied more than 2.4 million monthly claims for chemotherapy treatment and found little impact on outpatient chemotherapy treatment for the majority of oncology drugs identified as experiencing shortages between 2004 and 2011.
Categorized in -
Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program
In this study of patients 65 years and older, short-term postdischarge mortality did not appear to increase for black patients under the HRRP, suggesting that certain value-based payment policies can be implemented without harming black populations. However, mortality seemed to increase for white patients with HF and this situation warrants investigation.
Categorized in -
Joint Recommendations of USC-Brookings Schaeffer Initiative for Health Policy and AEI Scholars to Reduce Healthcare Costs
The experts recommendations to the Senate committee aimed at four main goals: improving incentives in private insurance, removing state regulatory barriers to provider market competition, improving incentives in the Medicare program, and promoting competition in the pharmaceutical market.
Categorized in -
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
Neeraj Sood penned an analysis of Louisiana’s new path to curing hepatitis C among its Medicaid and prison populations. It is the first state to implement a solution proposed by Sood in a National Academies of Sciences consensus report and in a leading medical journal.
Categorized in